Sorted By:


Medicare Monday: New research finds drugs not a key driver of Medicare Part B costs

PhRMA  |  Blog Post

Learn more at and check back with us on Medicare Monday.

New report confirms competitive market works; Net prices for medicines increased just 2.8 percent in 2015

PhRMA  |  Blog Post

Read more on how the competitive biopharmaceutical market controls costs and encourages the development of new treatments and cures at

Ken Frazier

PhRMA  |  Biography

Ken received his bachelor’s degree from The Pennsylvania State University and holds a J.D. from Harvard Law School.

UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard, New Report Shows

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $550 billion in the search for new treatments and cures, including an estimated $51.1 billion in 2013 alone.

PhRMA Statement on the Passing of Sen. Ted Kennedy

PhRMA  |  Press Release

PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines.

In the OECD other health care services will be ten times prescription medicine spending growth over next decade

PhRMA  |  Blog Post

To learn more check out our International Cost in Context information.

Innovative Oncology Medicines Have Led to Impressive Gains in Patient Survivorship

PhRMA  |  Press Release

“With more than 5,000 medicines in the biopharmaceutical pipeline, including more than 3,000 potential medicines for cancer patients, the future looks bright for continued progress.

Celebrating cardiovascular health on World Heart Day 2015

PhRMA  |  Blog Post

As we celebrate World Heart Day, it is important to remember the role of continued innovation in reducing the impact of heart disease and helping patients live longer, healthier lives.

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

PhRMA  |  Blog Post

Learn more about Medicare Part B at

Medicare Monday: Did You Know Four out of Five Part D Prescriptions Are Generic?

PhRMA  |  Blog Post

Strong R&D Investment the Best Bet to Slow Alzheimer’s Growing Threat

PhRMA  |  Blog Post

Building on these “failures,” researchers today are studying more than 80 medicines in development, to identify better treatments for patients.

New report and event examine the new era of vaccines

PhRMA  |  Blog Post

Watch the live discussions and panels here.

New report portrays flourishing pipeline

PhRMA  |  Blog Post

VIDEO: PhRMA CEO joins Fox Business anchor Neil Cavuto to discuss personal connection to value of innovation and White House meeting

PhRMA  |  Blog Post

Visit .com/?

Paul A. Aines Named PhRMA Executive Vice President and Chief Financial Officer; Del Persinger to Retire

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit:

Celebrating hope for patients and families on World Heart Day 2016

PhRMA  |  Blog Post

World Heart Day is a reminder that innovation helps reduce the impact of heart disease on patients and families.

Going boldly together: New advancements and new anniversaries

PhRMA  |  Blog Post

Researchers are continuously learning new, updated methods to enable organ recipients to live longer, more robust lives.

PhRMA Foundation Launches New Web Platform

PhRMA  |  Blog Post

Later this year, we’ll be launching educational modules for health care professionals developed in partnership with the National Institutes of Health (NIH) and the American Society of Clinical Pharmacology and Therapeutics (ASCPT).

Rep. Clyburn among speakers at “Research in Your Backyard” press conference

PhRMA  |  Press Release

“Clinical trials provide an important message of hope for patients who seek new treatment for unmet medical needs.

ICYMI: The New Era of Medicine initiative spotlights genomics in NYC

PhRMA  |  Blog Post

Genomics technologies have allowed us to design rapid response platform technologies: those could be our best bet for the rapid production and scale up of a new vaccine.” - Ripley Ballou, Vice President of Vaccines, GSK Click here to watch the full video and learn more at

Innovation Spotlight: A New Era in Medicine

PhRMA  |  Video

Today, a new era in vaccines is helping to prevent and eliminate disease in novel ways.

ICYMI: New study shows medicines advance life expectancy for HIV patients

PhRMA  |  Blog Post

Just in the last 10 years, 15 new medicines for HIV/AIDS were approved by the U.S.

ICYMI – IMS Institute – Branded net medicine price increases “lowest in past five years”

PhRMA  |  Blog Post

Learn more at

Medicamentos en Desarrollo para la Diabetes

PhRMA  |  Report

Para muchos pacientes, un diagnóstico de diabetes afecta casi todos los aspectos de, su vida, incluidas las preocupaciones de una dieta especial y otros cambios en el estilo de vida, así como los medicamentos que a diario deben tomar para manejar los niveles de glucosa en la sangre.

Request for Information: Center for Medicare and Medicaid Services - Innovation Center New Direction

PhRMA  |  Policy Paper

PhRMA is pleased to submitt comments on the Center for Medicare & Medicaid Services (CMS) Request for Information (RFI) on the New Directon for the Innovation Center (CMMI).

You have reviewed the first 75 results out of 2100. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next